Resources

Contraceptive Pearl: Testosterone Is Not Contraception

Sign up to Receive Contraceptive Pearls Monthly! If you enjoyed this Contraceptive Pearl, sign up to receive them in your inbox! Contraceptive Pearls are released on the third Tuesday of every month!


Written by Lily Van Tongeren, MD, AAHIVS

Testosterone is a fundamental part of gender-affirming medical care for many nonbinary and transmasculine people. For many patients, testosterone-induced amenorrhea is desired and affirming. But the absence of menstrual bleeding does not reliably mean that someone is not ovulating or cannot become pregnant. Nearly half of transmasculine adolescents and young adults with a uterus report having sex with sperm-producing partners.

Testosterone often thins the endometrium and partially suppresses the hypothalamic-pituitary-ovarian axis. That suppression varies and may come and go, and ovulation can happen without bleeding. A 2026 systematic review of 57 studies in the American Journal of Obstetrics and Gynecology found that testosterone generally suppresses menses, but breakthrough bleeding and ovulatory activity occurred in a substantial proportion of users.

The misconception that testosterone is contraception is common. In a 2018 survey, 16.4% of respondents believed testosterone was a form of contraception, and 5.5% reported that a healthcare provider had told them it was.

Testosterone exposure during pregnancy also matters. It is contraindicated in pregnancy because of potential virilization of the fetus. Pregnancy can go unrecognized in someone who is amenorrheic or has irregular bleeding on testosterone. Patients who use emergency contraception while amenorrheic should have a pregnancy test within two to four weeks.7 Patients who want to become pregnant should stop testosterone before trying to conceive. Fertility may return soon after stopping: in available studies, menses resumed within 6 months and most participants conceived within 6 months, although these data are self-reported and limited.4

The 2024 CDC U.S. Selected Practice Recommendations now explicitly state that testosterone might not prevent pregnancy and recommend contraceptive counseling and services for patients at risk of pregnancy who do not desire it.5,7 WPATH SOC8 and ACOG similarly recommend discussing contraception with transgender and gender-diverse people whose sexual activity could result in pregnancy.8,9

Contraceptive counseling with gender-diverse patients comes with individual and system-level barriers, including dysphoria, concerns about hormones, limited access, and prior negative healthcare experiences. Still, nearly every contraceptive option is available. Method choice should be patient-led and account for efficacy, bleeding goals, dysphoria, route of administration, privacy, procedural preferences, and cost.


RHAP Resources:

Your Birth Control Choices Fact Sheet

Birth Control Across the Gender Spectrum

Download and print our resources for free from our website or visit our store to buy physical copies!


Partner Resources:

Reproductive Health Hotline (ReproHH): A free, confidential phone service (1-844-737-7644) offering evidence-based clinical information for healthcare providers across the US who have questions related to sexual and reproductive health.


Sources:

1. Anderson DJ, Bearak JM, Grimstad FW, Palanee-Phillips T, van der Straten A. Biomedical innovations in contraception: gaps, obstacles, and solutions for sexual and reproductive health. Lancet. 2025;406(10515):2119-2132. doi:10.1016/S0140-6736(25)01187-0

2. van Vugt WLJ, van den Boogaard E, van der Tuuk K, et al. Gynecologic function and dysfunction in transmasculine and gender-diverse individuals using testosterone therapy: a systematic review. Am J Obstet Gynecol. 2026;235(1):33-71. doi:10.1016/j.ajog.2026.01.036

3. Taub RL, Ellis SA, Neal-Perry G, Magaret AS, Prager SW, Micks EA. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol. 2020;223(2):229.e1-229.e8. doi:10.1016/j.ajog.2020.01.059

4. Mattawanon N, Spencer JB, Schirmer DA 3rd, Tangpricha V. Fertility preservation options in transgender people: A review. Rev Endocr Metab Disord. 2018;19(3):231-242. doi:10.1007/s11154-018-9462-3

5. Light A, Wang LF, Zeymo A, Gomez-Lobo V. Family planning and contraception use in transgender men. Contraception. 2018;98(4):266-269. doi:10.1016/j.contraception.2018.06.006

6. Obedin-Maliver J, Snow A, Ragosta S, et al. Contraceptive use among transgender men and gender diverse individuals in the United States: Reasons for use, non-use, and methods used for pregnancy prevention. Contraception. 2025;141:110719. doi:10.1016/j.contraception.2024.110719

7. Curtis KM, Nguyen AT, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(3):1-77. Published 2024 Aug 8. doi:10.15585/mmwr.rr7303a1

8. Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-S259. Published 2022 Sep 6. doi:10.1080/26895269.2022.2100644

9. American College of Obstetricians and Gynecologists. Health care for transgender and gender diverse individuals: ACOG Committee Opinion No. 823. Obstetrics and Gynecology. 2021;137(3):e75-e88. doi:10.1097/AOG.0000000000004294


Sign up to Receive Contraceptive Pearls Monthly!

If you enjoyed this Contraceptive Pearl, sign up to receive them in your inbox! Contraceptive Pearls are released on the third Tuesday of every month!


Sign up to Receive Insights Monthly!

If you enjoyed this Pearl article, then check out Insights! Insights are monthly e-newsletters offering primary care clinicians evidence-based education on abortion and early pregnancy loss care (miscarriage). Read our latest Insights on our website. You can sign up to have Insights delivered to your inbox! Insights are released on the fourth Tuesday of every month!


Pharma-free: The Reproductive Health Access Project does not accept funding from pharmaceutical companies. We do not promote specific brands of medication or products. The information in the Pearls is unbiased, based on science alone.